No Picture
News

Avidity Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, June 16, 2020 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs™), today announced the closing o… […]

No Picture
News

Biocept Announces Pricing of $10.3 Million Registered Direct Offering Priced At-The-Market

SAN DIEGO, April 14, 2020 /PRNewswire/ –?Biocept, Inc. (NASDAQ: BIOC) (“Biocept” or the “Company”), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes … […]

No Picture
News

Biocept Announces Pricing of $10.3 Million Registered Direct Offering Priced At-The-Market

SAN DIEGO, April 14, 2020 /PRNewswire/ –?Biocept, Inc. (NASDAQ: BIOC) (“Biocept” or the “Company”), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes … […]